tradingkey.logo

Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

ReutersApr 10, 2025 8:52 PM

- Shuttle Pharmaceuticals Holdings Inc SHPH.O:

  • SHUTTLE PHARMACEUTICALS- FILES PROVISIONAL PATENT APPLICATION FOR PSMA LIGAND CONJUGATES TO TREAT PROSTATE CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI